Get the Stockscreener App
4.33
0.00%
0.00
After Hours:
4.58
0.25
+5.77%
Lantern Pharma Inc Stock (LTRN) Forecast
The Lantern Pharma Inc (LTRN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.76, representing a +148.58% increase from the current price of $4.33. The highest analyst price target is $15.27, and the lowest is $6.2556.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LTRN Price Target
Average 7.6393
(+76.43% Upside)
Is Lantern Pharma Inc (LTRN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.51 | Neutral |
| STOCH(9,6) | 19.05 | Buy |
| STOCHRSI(14) | 10.26 | Buy |
| MACD(12,26) | 0.1169 | Sell |
| ADX(14) | 36.72 | Buy |
| William %R | -88.50 | Buy |
| CCI(14) | -97.81 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.738
Sell
|
4.6374
Sell
|
| MA20 |
4.8145
Sell
|
4.6075
Sell
|
| MA50 |
4.1073
Buy
|
4.2665
Buy
|
| MA100 |
3.7681
Buy
|
4.0897
Buy
|
| MA200 |
4.2459
Buy
|
4.1681
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, LTRN could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on LTRN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 46.51 indicates that LTRN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.05 indicates that LTRN is oversold. This indicates that LTRN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.26 indicates that LTRN is oversold. This suggests that LTRN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 36.72 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -97.81 indicates that LTRN is still oversold but not to an extreme extent.
Long-term LTRN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lantern Pharma Inc financial reports and earnings history, Lantern Pharma Inc (LTRN) stock could reach $2.4931 by 2030, $19.25 by 2040 and $23.10 by 2050. See the projected annual prices until 2050 of the Lantern Pharma Inc stock below:
- Lantern Pharma Inc (LTRN) is expected to reach an average price of $13.84 in 2035, with a high prediction of $14.25 and a low estimate of $14.06. This indicates an $219.64% rise from the last recorded price of $4.33.
- Lantern Pharma Inc (LTRN) stock is projected to chart a bullish course in 2040, with an average price target of $17.99, representing an $315.54% surge from its current level. The forecast ranges from a conservative $19.00 to a sky-high $19.25.
- Our analysts predict Lantern Pharma Inc (LTRN) to jump 377.73% by 2045, soaring from $21.02 to an average price of $20.69, potentially reaching $21.44. While $21.02 is the low estimate, the potential upside is significant.
- Lantern Pharma Inc (LTRN) stock is expected to climb by 2050, reaching an average of $22.89, a $428.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.10 and $22.93, respectively, highlighting the market's uncertainty.
Lantern Pharma Inc Stock (LTRN) Year by Year Forecast
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2025
Lantern Pharma Inc Stock (LTRN) is expected to reach an average price of $7.7357 in 2025, with a high prediction of $15.27 and a low estimate of $0.2001. This indicates an +78.65% rise from the last recorded price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $9.9628 | $6.2556 | $15.27 | +130.09% |
| April, 2025 | $6.9613 | $5.6956 | $12.80 | +60.77% |
| May, 2025 | $7.1742 | $4.7928 | $8.1971 | +65.69% |
| June, 2025 | $7.417 | $6.1799 | $8.6056 | +71.29% |
| July, 2025 | $6.0556 | $4.6556 | $7.6779 | +39.85% |
| August, 2025 | $3.8085 | $2.6785 | $7.1528 | -12.04% |
| September, 2025 | $5.9813 | $3.7342 | $7.2599 | +38.14% |
| October, 2025 | $3.5599 | $1.6199 | $5.972 | -17.79% |
| November, 2025 | $3.0327 | $2.0313 | $3.9056 | -29.96% |
| December, 2025 | $0.4813 | $0.2001 | $3.1884 | -88.88% |
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2026
The predicted value for Lantern Pharma Inc (LTRN) in 2026 is set at an average of $0.8171. Estimates vary from a peak of $1.627 to a trough of $0.00728, indicating an -81.13% surge from the present price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9341 | $0.00728 | $1.627 | -78.43% |
| February, 2026 | $0.623 | $0.2644 | $1.3056 | -85.61% |
| March, 2026 | $0.1602 | $0.3259 | $0.6241 | -96.30% |
| April, 2026 | $0.2484 | $0.6316 | $0.4187 | -94.26% |
| May, 2026 | $0.4013 | $0.0602 | $1.3113 | -90.73% |
| June, 2026 | $0.3559 | $0.117 | $0.6627 | -91.78% |
| July, 2026 | $0.6587 | $0.793 | $0.5046 | -84.79% |
| August, 2026 | $0.5645 | $0.9624 | $0.8759 | -86.96% |
| September, 2026 | $1.0159 | $0.7831 | $0.8112 | -76.54% |
| October, 2026 | $0.353 | $0.4688 | $0.6302 | -91.85% |
| November, 2026 | $0.9302 | $0.9073 | $0.6416 | -78.52% |
| December, 2026 | $1.1216 | $1.1916 | $0.8778 | -74.10% |
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lantern Pharma Inc (LTRN) is $0.705, with a high forecast of $1.3969 and a low forecast of $0.0132. This indicates an -83.72% decrease from the last price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0188 | $1.4923 | $1.3502 | -76.47% |
| February, 2027 | $0.5059 | $0.6574 | $0.4509 | -88.32% |
| March, 2027 | $0.0726 | $0.1024 | $0.7226 | -98.32% |
| April, 2027 | $0.6455 | $0.0745 | $0.8155 | -85.09% |
| May, 2027 | $0.0717 | $0.1974 | $0.8569 | -98.34% |
| June, 2027 | $0.6281 | $0.0903 | $0.4397 | -85.49% |
| July, 2027 | $0.1603 | $0.1903 | $0.2124 | -96.30% |
| August, 2027 | $0.0626 | $0.0769 | $0.6769 | -98.55% |
| September, 2027 | $1.2011 | $0.054 | $1.3211 | -72.26% |
| October, 2027 | $0.244 | $0.214 | $1.3969 | -94.36% |
| November, 2027 | $0.2368 | $0.0132 | $0.4797 | -94.53% |
| December, 2027 | $0.1854 | $0.0303 | $1.2526 | -95.72% |
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2028
In 2028, Lantern Pharma Inc (LTRN) is projected to reach an average price of $4.2136, with a high projection of $8.3896 and a low estimate of $0.0376. This indicates an -2.69% fall from the last price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9617 | $0.1889 | $0.4192 | -77.79% |
| February, 2028 | $1.5889 | $1.2703 | $1.3089 | -63.31% |
| March, 2028 | $0.1083 | $0.3203 | $1.5032 | -97.50% |
| April, 2028 | $0.2625 | $0.3552 | $0.2725 | -93.94% |
| May, 2028 | $0.1311 | $0.0376 | $0.5915 | -96.97% |
| June, 2028 | $0.4239 | $0.1168 | $0.6681 | -90.21% |
| July, 2028 | $0.4468 | $0.0954 | $1.9111 | -89.68% |
| August, 2028 | $4.1854 | $0.5226 | $8.3896 | -3.34% |
| September, 2028 | $1.6282 | $1.4183 | $4.7211 | -62.40% |
| October, 2028 | $6.9171 | $1.7639 | $5.1271 | +59.75% |
| November, 2028 | $6.04 | $5.7729 | $5.8157 | +39.49% |
| December, 2028 | $1.5543 | $6.1586 | $6.3357 | -64.10% |
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2029
The 2029 price forecast for Lantern Pharma Inc Stock (LTRN) is $3.7092 on average, with a high prediction of $7.1999 and a low estimate of $0.2184. This represents an -14.34% decrease from the previous price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.4272 | $1.4515 | $1.5514 | -67.04% |
| February, 2029 | $2.4185 | $0.6657 | $4.1962 | -44.15% |
| March, 2029 | $1.1358 | $1.2399 | $7.1999 | -73.77% |
| April, 2029 | $1.4901 | $1.6301 | $1.0644 | -65.59% |
| May, 2029 | $2.127 | $0.4508 | $4.077 | -50.88% |
| June, 2029 | $1.7873 | $1.6285 | $4.0799 | -58.72% |
| July, 2029 | $1.1584 | $0.2856 | $2.7756 | -73.25% |
| August, 2029 | $1.7856 | $0.5256 | $7.0427 | -58.76% |
| September, 2029 | $0.4013 | $0.2184 | $4.6784 | -90.73% |
| October, 2029 | $0.7716 | $1.4873 | $1.053 | -82.18% |
| November, 2029 | $0.4259 | $0.6888 | $0.7112 | -90.16% |
| December, 2029 | $2.4802 | $1.1345 | $0.9872 | -42.72% |
Lantern Pharma Inc Stock (LTRN) Price Forecast for 2030
Lantern Pharma Inc Stock (LTRN) is expected to reach an average price of $4.4631 in 2030, with a high forecast of $7.306 and a low forecast of $1.6202. This signifies an +3.07% surge from the last price of $4.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.8031 | $2.7745 | $2.4931 | -12.17% |
| February, 2030 | $1.5274 | $1.6202 | $0.8616 | -64.73% |
| March, 2030 | $4.0517 | $3.2059 | $3.7117 | -6.43% |
| April, 2030 | $4.386 | $4.596 | $4.1774 | +1.29% |
| May, 2030 | $5.9088 | $5.0031 | $5.2488 | +36.46% |
| June, 2030 | $6.8331 | $6.886 | $6.5131 | +57.81% |
| July, 2030 | $7.566 | $7.0817 | $7.306 | +74.73% |
| August, 2030 | $7.0003 | $7.1917 | $7.1046 | +61.67% |
| September, 2030 | $6.6346 | $7.4775 | $7.2075 | +53.22% |
| October, 2030 | $6.2075 | $6.0989 | $6.3832 | +43.36% |
| November, 2030 | $6.8618 | $6.4661 | $6.6118 | +58.47% |
| December, 2030 | $7.0161 | $7.1961 | $6.9077 | +62.03% |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):